Episode 27: The rise and fall of Ryman – what’s next?

Ryman Healthcare has been in the news recently, raising $1bn of new equity – it’s second raise in two years. Pre-Covid, the company was a top performing stock, so what went wrong, and what’s ahead? Milford Portfolio Manager Sam Trethewey talks to Ryan Bridge about Ryman’s turnaround.

 

This podcast is intended to provide general information only. It does not take into account your investment needs or personal circumstances. It is not intended to be viewed as investment or financial advice. Should you require financial advice you should always speak to a Financial Adviser. Past performance is not a reliable indicator of future performance. Milford is an active fund manager with views and portfolio positions subject to change. Milford Funds Limited is the issuer of the Milford KiwiSaver Plan and the Milford Investment Funds. Please read the relevant Milford Product Disclosure Statement at milfordasset.com. Before investing, you may wish to seek financial advice. The disclosure statements of all Milford Financial Advisers contain more information and are available for free on request. For more information and to see our Financial Advice Provider Disclosure statement, please visit milfordasset.com/getting-advice